글로벌 돌연변이 분석 시장 – 2028년까지의 산업 동향 및 예측

돌연변이 분석 시장의 시장 분석 및 통찰력

Data Bridge Market Research는 돌연변이 분석 시장이 2021-2028년 예측 기간 동안 약 12.10%의 CAGR을 보일 것이라고 분석합니다. 선진 의약품에 대한 유전체학 지원의 전반적인 성장, 의료 기기와 관련된 연구 개발 능력에 대한 집중 증가, 첨단 의료 기술 도입, 특히 개발도상국에서 의료 인프라 개발 에 대한 지출 증가가 돌연변이 분석 시장 성장에 기여하는 주요 요인입니다.

돌연변이 분석은 유전체 분석의 한 분야로, DNA 서열이 일부 내부 및 외부 요인으로 인해 변경됩니다. 돌연변이 분석은 차세대 시퀀싱의 돌연변이 탐지에 사용되는 신뢰할 수 있는 분석 개발입니다.

전 세계적으로 신생아 유전자 시퀀싱 프로그램의 유행이 급증하는 것은 시장 성장을 촉진하는 주요 요인입니다. 임상 차세대 시퀀싱(NSG) 검사에서 의료 기술 발전에 대한 관심이 높아지고 유전체 산업이 성장하는 것도 또 다른 시장 성장 요인입니다. 연구 개발 능력 향상, 비침습적 암 검진 기술의 발전 급증, 유전체 산업에 대한 정부의 지원 증가는 수익성 있는 시장 성장 기회를 더욱 창출할 것입니다.

그러나 장비와 관련된 높은 비용은 시장 성장률을 탈선시킬 것입니다. 숙련된 전문가와 의료 전문 지식의 부족은 시장에 더 큰 과제를 안겨줄 것입니다. 또한, 후진 및 저개발 경제권에서의 인식 부족도 시장 성장률을 저해할 것입니다.

This mutational analysis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on mutational analysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Mutational Analysis Market Scope and Market Size

The mutational analysis market is segmented on the basis of type, product, technique and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• The global mutational analysis market is segmented on the basis of type into missense mutation, nonsense mutation, insertion, deletion, duplication, frame shift mutation and repeat expansion.
• On the basis of product, the mutational analysis market is segmented into enzyme and substrate.
• On the basis of technique, the mutational analysis market is segmented into denaturing gradient gel electrophoresis (DGGE), constant denaturing gel electrophoresis (CDGE), temporal temperature gradient gel electrophoresis (TTGE), single- strand conformation polymorphism (SSCP), protein truncation test (PTT) and high resolution melt.   
• On the basis of end user, the mutational analysis market is segmented into academic research institutes, contract research organization and others.

Mutational Analysis Market Country Level Analysis

The mutational analysis market is analysed and market size insights and trends are provided by country, type, product, technique and end user as referenced above.

The countries covered in the mutational analysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the mutational analysis market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the prevailing advanced healthcare technologies, supportive government policies for research and development proficiencies and growing prevalence of major players. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the growing genomics industry.

The country section of the mutational analysis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare infrastructure growth installed base and new technology penetration

The mutational analysis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for mutational analysis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the mutational analysis market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Mutational Analysis Market Share Analysis

The mutational analysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to mutational analysis market.

돌연변이 분석 시장 보고서에서 다루는 주요 기업으로는 Novartis AG, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Agilent Technologies Inc, GENERAL ELECTRIC COMPANY, PerkinElmer, Inc., QIAGEN, Eurofins Scientific, Quest Diagnostics Incorporated., Novogene Corporation., Promega Corporation., Luminex Corporation, Takara Bio Inc., Danaher., BioIVT., Elevate Scientific., Oxford Gene Technology IP Limited, Pacific Biosciences of California, Inc. 등이 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-46697